Company Overview
Snapshot
Founded in April 2019, Venacore operates with 1–10 employees. The company has secured funding across one round. Med Venture Holdings led its Seed round in May 2019.
Business overview
Venacore is a medical device company focused on developing structural intervention occluders for congenital heart defects. Its core technology is designed to effectively anchor and occlude in large vessels where traditional plugs may fail. The company operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Medical Treatment & Therapeutics categories, serving healthcare providers.
Log in to access full profile ›Company Intelligence Q&A
- What is Venacore's primary focus?
- Venacore is developing a medical device for structural intervention, specifically an occluder for the closure of congenital heart defects.
- When was Venacore founded?
- Venacore was founded in April 2019.
- What stage is Venacore currently in?
- Venacore is currently in the R&D product stage and Seed funding stage.
- What problem does Venacore's device aim to solve?
- Venacore's device is designed to anchor and occlude effectively in large vessels, addressing limitations where other plugs for congenital heart defects may fail.